Steve Cutler, CEO of ICON Plc, said: "Our outlook for this year reflects an ... ICLR was down by 9.12 percent at $198.10 in the pre-market trade on the Nasdaq. The views and opinions expressed ...

TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.